DX

Leading Infectious Diseases & Molecular Diagnostics Summit

FutureDx Summit 2026

The Future of Infectious Diseases and Molecular Diagnostics connecting cutting-edge scientific innovation with real-world clinical and public health applications.

Date 9-10 September 2026
Location London, UK
Edition Launch Edition
Countdown
00d
00h
00m
00s
0+
Expected Attendees
0
Conference Days
0+
Expert Speakers
0
Sponsor Tiers
01
Event Overview

Future Dx Summit,
2026

The FutureDX Summit is a premier international conference focused on infectious diseases and molecular diagnostics. It is designed to connect cutting-edge scientific innovation with real-world clinical and public health applications.

As global health challenges such as emerging pathogens, antimicrobial resistance, and growing immunocompromised populations continue to intensify, rapid, accurate, and scalable molecular diagnostics have become essential.

Conceptualised and curated by Convolign Business Consulting, this high-impact summit in London brings together diagnostic professionals, clinicians, laboratory leaders, technologists, biotech innovators, and public health stakeholders from across the globe.

About the Summit

Next-Gen Innovations

Multiplex PCR, genomic sequencing, and lateral flow technologies pushing the boundaries of infectious disease detection.

AI & Predictive Analytics

How artificial intelligence forecasts outbreaks and guides personalised treatment strategies for infectious disease management.

Combating AMR

The role of diagnostics in early antimicrobial resistance detection, stewardship programmes, and resistance surveillance.

Point-of-Care Solutions

Innovations in rapid, field-deployable testing for emergency care, remote locations, and low-resource settings worldwide.

Climate Change Impact

How changing climate conditions influence disease transmission patterns and drive the evolution of diagnostics.

WHO SHOULD ATTEND
Hospitals & Clinical Labs

Infectious disease, pathology, microbiology & genomics professionals

Biotech & Pharma Leaders

CEOs, R&D Scientists & Diagnostic Developers

Academic Researchers

Professors and PIs leading molecular research

Public Health Authorities

Government agencies, UKHSA, ECDC & global health strategists

Register
WHY ATTEND

Five reasons to be
in the room

01
Stay Ahead of Innovation

Gain direct access to AI-enabled platforms and next-gen clinical workflows transforming diagnostics globally.

02
Build Transformative Connections

Network with 120+ key stakeholders through structured sessions and networking events.

03
Learn from Global Experts

Hear from internationally recognised leaders in precision medicine and molecular diagnostics.

04
Practical, Actionable Insights

Validated case studies and models ready for implementation.

05
Unbiased, Expert-Curated Content

Agenda designed by industry experts — not vendor driven.

Attendee Demographics

Who Will Be
In The Room

Placeholder percentages — update with confirmed figures before launch.

Molecular Diagnostics Clinical Microbiology Biotech & Pharma R&D Public Health Policy AI & Bioinformatics Point-of-Care Testing AMR & Stewardship Regulatory Affairs
Audience by Sector
Clinical Laboratories & Hospitals 0%
IVD & Diagnostics Companies 0%
Regulatory & Government 0%
Seniority Breakdown
Senior Leadership (VP+) 0%
Scientists & PIs 0%
Managers & Commercial Leads 0%
Emerging Leaders & Postdocs 0%
Market Opportunity

The Global
Diagnostics Market

The infectious disease diagnostics landscape represents one of the fastest-growing sectors in UK and global life sciences — and why FutureDX Summit sits at its centre.

$0
UK Molecular Diagnostics Market by 2030

Growing at ~3.7% CAGR (2025–2030), driven by PCR, genomic testing & advanced diagnostics

0%
NHS Hospital Adoption of Molecular Testing

Percentage of NHS trusts using PCR and genomic sequencing in workflows

0+
Diagnostics & Biotech Firms in the UK

Active molecular diagnostics and infectious disease companies

0%
Rise in AMR-Related Hospital Admissions

Increase in UK hospital admissions linked to antimicrobial-resistant infections

0%
AI Adoption in UK Diagnostic Workflows

Healthcare systems integrating AI/ML tools for disease detection

0%
Demand Growth for Point-of-Care Testing

Increase in diagnostics use in emergency and community care settings

Expert Speaker Panel

Speakers for FutureDX 2026

FutureDX Summit 2026 is bringing together 25+ world-class speakers from infectious disease science, molecular diagnostics, and global public health.

Angela Douglas MBE
Angela Douglas MBE

President

British In Vitro Diagnostics Association
Helen_Dent
Helen Dent

CEO

British In Vitro Diagnostics Association
Peter Gayo Munthali
Peter Gayo Munthali

Antimicrobial Stewardship Lead Training Programme Director West Midlands (Infectious diseases/ Microbiology Training)

University Hospital of Coventry and Warwickshire
Prof. Adriana Calderaro
Prof. Adriana Calderaro

Director of the Unit of Clinical Microbiology. Director of the Unit of Clinical Virology

University Hospital of Parma
Elfatih Mustafa Awad-el-kariem
Elfatih Mustafa Awad-el-kariem

Consultant Microbiologist & Director for Infection Prevention & Control (DIPC) Basildon and Thurrock NHS University Hospital, Mid and South Essex NHS Foundation Trust

Nethermayne Basildon
Susie Jeerwood
Susie Jeerwood

Consulant in Public Health Infection

Nipun Sawhney
Nipun Sawhney

Principal Investigator And Project Lead for Medical Research Council And Wellcome Trust IAA Project

University of Cambridge
Peter Obami
Peter Obami

Specialist Biomedical Scientist Pathology IT & Applications Officer/EPR Workstream Lead

Barking, Havering and Redbridge University Hospitals
Dr Noha El Sakka
Dr Noha El Sakka

Vice President - Royal College of Pathologists, Clinical Director - Laboratory Medicine. Consultant Medical Microbiology and Virology, Lead Infection Prevention and Control Doctor - NHS Grampian, Honorary Clinical Senior Lecturer University of Aberdeen

NHS Grampian
Suparna Mitra
Suparna Mitra

Microbiome and AMR Research Lead

University of Leeds
Dipti Patel
Dipti Patel

Infection and Immunity Lead | Scientist/Manager

Imperial College Healthcare NHS Trust
Louis Grandjean
Louis Grandjean

Professor Infectious Diseases

UCL
Adapting to Evolving Landscapes
08:00

Registration & Morning Coffee

09:00

Keynote: The Future of Infectious Disease Diagnostics

09:45

Sepsis Diagnostics — Speed & Clinical Impact

10:30

Networking Coffee Break

11:00

Drug-Resistant TB — Diagnostic Challenge

12:00

BBV Screening in Community Settings

13:00

Networking Lunch

14:45

Rapid Diagnostic Services — Sponsor Session

17:00

Evening Drinks Reception

Download Agenda
Future of Diagnostics
09:00

AI in Diagnostics

10:30

Precision Medicine

12:00

Panel Discussion

14:00

Closing Keynote

Download Agenda
Conference Programme

Agenda at a glance

Two intensive days spanning the full diagnostics spectrum — from clinical science to AI, regulatory strategy, and global health.

Drinks Reception

End of Day 1

Event Networking

Both Days

1:1 Meetings

Both Days

Why It Works

A uniquely focused audience

Sponsoring FutureDX 2026 places your brand at the centre of the molecular diagnostic transformation. Unlike generic events, your technology is showcased in a curated, solution-focused discourse.

120+ High-Level Decision-Makers

Direct access to Lab Directors and Biotech CEOs with budget authority and procurement influence in infectious disease diagnostics.

Branded Speaking Opportunity

Diamond, Platinum, and Gold tiers include dedicated speaking time — positioning your brand as a scientific and commercial authority.

Drink Reception Access

All major tiers include Drink Reception passes — the premium networking moment of the summit where the most meaningful connections are made.

Measurable ROI

Post-event delegate lists, structured 1:1 meetings, and live solution-showcase slots give you trackable outcomes — not just brand impressions.

Solution-Focused Discourse

Sessions are designed to showcase your technology within expert-led content — as part of the scientific conversation, not as advertising.

First-Mover Advantage

As the inaugural edition, early sponsors gain maximum brand positioning in what will become the annual UK platform for infectious disease Dx.

Co-Located Event

Attend alongside BioShield Conference 2026

BioShield Conference 2026 is a premier gathering dedicated to biosecurity, infectious disease preparedness, and the science of protecting populations from biological threats. Running alongside FutureDX Summit, BioShield brings together global health security experts, public health officials, and life sciences innovators to address the most pressing biosecurity challenges of our time — making the combined event one of the most comprehensive infectious disease gatherings in the UK.

DATE
9–10 September 2026
LOCATION
London, UK
ATTENDEES
120+ Senior Professionals
EDITION
Launch Edition
Both conferences run simultaneously — delegates can attend sessions from either event.
Ready to Attend?

Join us at FutureDX 2026 — London, September

Three pass types from £649. Register early for the inaugural edition.

View Registration & Passes
Become a Sponsor

Showcase your brand — 5 tiers available

Direct access to 120+ infectious disease diagnostics decision-makers.

View Sponsorship Packages
Venue
London, UK

Full venue details will be shared with registered delegates. Central London venue — accessible by tube, rail, and air.

9–10 September 2026 · Registration from 08:00
Central London — tube, rail & airport access
Preferred hotel rates shared on registration
Contact Our Team

For registration, speaking, or sponsorship enquiries

Our team responds within 24 business hours. Reach us directly.

+1-617-604-3359 · +1-617-213-1431
Convolign Business Consulting LLP